TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis

被引:45
作者
Olivier, M [1 ]
Hainaut, P [1 ]
机构
[1] WHO, Int Agcy Res Canc, Grp Mol Carcinogenesis, F-69372 Lyon 08, France
关键词
breast cancer; TP53; mutations; carcinogens;
D O I
10.1006/scbi.2001.0390
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in the tumour suppressor gene TP53 occur in about 30% of breast cancers. We have used the IARC TP53 mutation database to analyse the pattern of mutations in breast cancers (1392 mutations). The global Pattern of mutations is similar to the one of most other cancers, but there is an excess of transversions on G bases in tumours from Western (USA and Europe) as compared to Eastern (Japan) countries. Moreover, the patterns of inherited TP53 mutations associated with breast cancer; differ from those of somatic mutations. These differences support the hypothesis that a fraction of breast cancer mutations occur as a consequence of environmental exposures.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 34 条
  • [1] Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
    Aas, T
    Borresen, AL
    Geisler, S
    SmithSorensen, B
    Johnsen, H
    Varhaug, JE
    Akslen, LA
    Lonning, PE
    [J]. NATURE MEDICINE, 1996, 2 (07) : 811 - 814
  • [2] Alsner J, 2000, CLIN CANCER RES, V6, P3923
  • [3] Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk
    Ambrosone, CB
    Freudenheim, JL
    Graham, S
    Marshall, JR
    Vena, JE
    Brasure, JR
    Michalek, AM
    Laughlin, R
    Nemoto, T
    Gillenwater, KA
    Harrington, AM
    Shields, PG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (18): : 1494 - 1501
  • [4] Angèle S, 2000, CLIN CANCER RES, V6, P3536
  • [5] [Anonymous], 1997, Cancer incidence in five continents
  • [6] Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
    Berns, EMJJ
    van Staveren, IL
    Look, MP
    Smid, M
    Klijn, JGM
    Foekens, JA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (07) : 1130 - 1136
  • [7] Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53
    Denissenko, MF
    Pao, A
    Tang, MS
    Pfeifer, GP
    [J]. SCIENCE, 1996, 274 (5286) : 430 - 432
  • [8] Dogliotti E, 1998, RECENT RES CANCER, V154, P97
  • [9] High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers
    Eiriksdottir, G
    Barkardottir, RB
    Agnarsson, BA
    Johannesdottir, G
    Olafsdottir, K
    Egilsson, V
    Ingvarsson, S
    [J]. ONCOGENE, 1998, 16 (01) : 21 - 26
  • [10] Geisler S, 2001, CANCER RES, V61, P2505